Calone to keynote health-focused Capital Forum

Venture capitalist David Calone.

Industry leaders, inventive entrepreneurs and hungry investors will come together Jan. 22 for the Long Island Capital Alliance’s Healthcare Capital Forum.

Featuring lightning-round business-plan presentations – just seven minutes each – from five upstart healthcare innovators across Long Island’s healthcare and investor markets, the forum is scheduled to run from 8 a.m. to 11 a.m. at the RXR Center in Melville.

David Calone, president and CEO of Setauket VC firm Jove Equity Partners and a founder of the Long Island Emerging Technologies Fund, is slated to deliver the keynote address. Calone, who is a 2016 candidate for the U.S. House of Representatives in the 1st Congressional District, called the forum an opportunity to “help more companies be formed, and help more companies grow.”

“Events like this are what we need to build the innovation economy on Long Island, with healthcare being a key piece of that,” Calone told Innovate LI.

While such business-development themes must extend to all regional industries, healthcare “is going to be one of the cornerstones of the Island’s economic future,” he added, noting the LIETF – in conjunction with regional business booster Accelerate Long Island – helped launch 10 companies emerging from Island-based R&D, “most of which were health- and bio-related.”

Following Calone’s opening remarks, attendees and a four-member investor panel will hear business pitches from Remote Medical Technologies, which focuses on real-time, high-definition video communications among pathologists, surgeons and radiologists; Theragnostic Technologies, promoting a “next-generation MRI contrast agent” that is “uniquely safe” for kidney patients and offers superior images and longer imaging time, plus other “nano-based multi-functionality;” and Soteria Technologies, makers of Oxxy/Gen, the world’s first affordable personal-escape respirator.

Also presenting: High Pressure Processing, peddling a natural, water-based food-purification process, and the big brains behind the Neural Tourniquet, a bioelectric device purported to staunch blood loss through electronic nerve stimulation, based on science from the Northwell Health system’s Feinstein Institute for Medical Research.

The investor panelists are expected to include David Weild IV, CEO of tech-focused “capital facilitation platform” Weild & Co.; Lishan Aklog, chairman and CEO of venture-backed medical-device incubator Pavilion Medical Innovations and co-managing partner of advisory and investment firm HCFP; KEC Ventures partner and HCFP chief executive Joshua Lamstein; and serial investor Harvey Brofman, a seasoned veteran of healthcare informatics currently running Nine 4-Bit Slices, an investment firm focused on healthcare, analytics, social media and other high-tech markets.

The Healthcare Capital Forum, which includes a continental breakfast, is free for LICA members and $65 per nonmember. Registration is required.

In addition to highlighting the five presenting companies, Calone noted, the event promises to promote regional innovation in general by pairing big thinkers with big spenders.

“This is not just about providing healthcare to people, but innovation within health,” the keynote speaker noted. “We have an opportunity here to not just create new ways to provide care to the people who live here, but to come up with innovations that can literally change the world.”